• LEO Pharma announces Positive Topline Phase 2b Results for Temtokibart in Moderate-to-Severe Atopic Dermatitis | Morningstar

    Source: Buzz FX / 09 May 2025 06:36:28   America/New_York

    LEO Pharma announces Positive Topline Phase 2b Results for Temtokibart in Moderate-to-Severe Atopic Dermatitis LEO Pharma announces Positive Topline Phase 2b Results for Temtokibart in Moderate-to-Severe Atopic Dermatitis - Temtokibart achi https://www.morningstar.com/news/business-wire/20250509981022/leo-pharma-announces-positive-topline-phase-2b-results-for-temtokibart-in-moderate-to-severe-atopic-dermatitis
Share on,